104 related articles for article (PubMed ID: 29419534)
21. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Nagamine T
Asian J Psychiatr; 2020 Apr; 50():102031. PubMed ID: 32272360
[No Abstract] [Full Text] [Related]
22. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
23. What Interventions Improve Outcomes for the Patient Who Is Depressed and in Pain?
Brammer SV
Pain Manag Nurs; 2018 Dec; 19(6):580-584. PubMed ID: 30342882
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine in Painful Diabetic Neuropathy: A Systematic Review.
Hossain SM; Hussain SM; Ekram AR
Clin J Pain; 2016 Nov; 32(11):1005-1010. PubMed ID: 26710221
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study.
Pauls Q; Durkalski-Mauldin V; Brawman-Mintzer O; Lawrence C; Whichard R; Cotton PB
Dig Dis Sci; 2016 Sep; 61(9):2704-9. PubMed ID: 27165434
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
Mowla A; Boostani S; Dastgheib SA
J Clin Psychopharmacol; 2016 Dec; 36(6):720-723. PubMed ID: 27811556
[TBL] [Abstract][Full Text] [Related]
27. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
Lassen D; Ennis ZN; Damkier P
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
[TBL] [Abstract][Full Text] [Related]
28. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.
Fan QY; Xue R; Li Y; Zhang TT; He XH; Fan SY; Li YF; Zhong BH; Zhang YZ; Li J
CNS Neurosci Ther; 2016 Aug; 22(8):700-6. PubMed ID: 27207183
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
Carlos F; Espejel L; Novick D; López R; Flores D
Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
[TBL] [Abstract][Full Text] [Related]
31. [Persistent Genital Arousal Disorder Treated with Duloxetine: A Case Report].
Gündüz N; Polat A; Turan H
Turk Psikiyatri Derg; 2019; 30(1):67-70. PubMed ID: 31170309
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.
Xu Y; Bai SJ; Lan XH; Qin B; Huang T; Xie P
Braz J Med Biol Res; 2016 May; 49(6):. PubMed ID: 27240293
[TBL] [Abstract][Full Text] [Related]
33. [Economic evaluation of desvenlafaxine in the treatment of major depressive disorder in Spain].
Rejas Gutiérrez J; Blanca Tamayo M; Gascón Barrachina J; Armada Peláez B
Rev Psiquiatr Salud Ment; 2016; 9(2):87-96. PubMed ID: 26475204
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression.
Sindhu P; Kumar S; Iqbal B; Ali J; Baboota S
J Psychiatr Res; 2018 Apr; 99():83-95. PubMed ID: 29427845
[TBL] [Abstract][Full Text] [Related]
35. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
36. Duloxetine for treating painful neuropathy or chronic pain.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
[TBL] [Abstract][Full Text] [Related]
37. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia.
Amoako AO; Brown C; Riley T
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911354
[TBL] [Abstract][Full Text] [Related]
38. Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.
Yang M; Qian C; Liu Y
Pain Med; 2015 Nov; 16(11):2075-83. PubMed ID: 26118704
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China.
Gao Y; Ning G; Jia WP; Zhou ZG; Xu ZR; Liu ZM; Liu C; Ma JH; Li Q; Cheng LL; Wen CY; Zhang SY; Zhang Q; Desaiah D; Skljarevski V
Chin Med J (Engl); 2010 Nov; 123(22):3184-92. PubMed ID: 21163113
[TBL] [Abstract][Full Text] [Related]
40. Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain.
Nagamine T
Psychiatry Clin Neurosci; 2018 Jan; 72(1):45-46. PubMed ID: 29064131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
